KR940005667A - 선형 펩타이드 - Google Patents

선형 펩타이드 Download PDF

Info

Publication number
KR940005667A
KR940005667A KR1019930011106A KR930011106A KR940005667A KR 940005667 A KR940005667 A KR 940005667A KR 1019930011106 A KR1019930011106 A KR 1019930011106A KR 930011106 A KR930011106 A KR 930011106A KR 940005667 A KR940005667 A KR 940005667A
Authority
KR
South Korea
Prior art keywords
compound
amount
cells
administering
administered
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
KR1019930011106A
Other languages
English (en)
Korean (ko)
Inventor
존치크 알프레트
펠딩 -하베르만 브룬힐데
멜저 귀도
디펜바흐 베아테
에이. 체리쉬 데이비드
Original Assignee
위르겐 호이만, 라인 하르트 슈틀러
메르크 파텐트 게젤샤프트 미트 베쉬랭크터 하프퉁
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 위르겐 호이만, 라인 하르트 슈틀러, 메르크 파텐트 게젤샤프트 미트 베쉬랭크터 하프퉁 filed Critical 위르겐 호이만, 라인 하르트 슈틀러
Publication of KR940005667A publication Critical patent/KR940005667A/ko
Withdrawn legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/06Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745Blood coagulation or fibrinolysis factors
    • C07K14/75Fibrinogen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Hematology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
KR1019930011106A 1992-06-18 1993-06-17 선형 펩타이드 Withdrawn KR940005667A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US90038592A 1992-06-18 1992-06-18
US900,385 1992-06-18

Publications (1)

Publication Number Publication Date
KR940005667A true KR940005667A (ko) 1994-03-22

Family

ID=25412429

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019930011106A Withdrawn KR940005667A (ko) 1992-06-18 1993-06-17 선형 펩타이드

Country Status (13)

Country Link
EP (1) EP0576898A2 (enExample)
JP (1) JPH0665290A (enExample)
KR (1) KR940005667A (enExample)
CN (1) CN1083075A (enExample)
AU (1) AU4125193A (enExample)
CA (1) CA2098535A1 (enExample)
CZ (1) CZ118593A3 (enExample)
HU (1) HUT66469A (enExample)
MX (1) MX9303638A (enExample)
NO (1) NO932237L (enExample)
PL (1) PL299367A1 (enExample)
SK (1) SK57693A3 (enExample)
ZA (1) ZA934353B (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5753230A (en) 1994-03-18 1998-05-19 The Scripps Research Institute Methods and compositions useful for inhibition of angiogenesis
US5767071A (en) * 1995-06-07 1998-06-16 Ixsys Incorporated Sevenmer cyclic peptide inhibitors of diseases involving αv β3
US5780426A (en) * 1995-06-07 1998-07-14 Ixsys, Incorporated Fivemer cyclic peptide inhibitors of diseases involving αv β3
PT951295E (pt) 1996-05-31 2010-07-29 Scripps Research Inst COMPOSIÎES PARA UTILIZAÆO NA INIBIÆO DE ANGIOGéNESE MEDIADA POR ALFA-V-BETA3
US6849712B1 (en) 1998-01-22 2005-02-01 Regents Of The University Of Minnesota Peptides with β1 integrin subunit dependent cell adhesion modulating activity

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5196511A (en) * 1989-12-01 1993-03-23 The Scripps Research Institute Peptides and antibodies that inhibit integrin-ligand binding

Also Published As

Publication number Publication date
EP0576898A3 (enExample) 1994-04-13
EP0576898A2 (en) 1994-01-05
CZ118593A3 (en) 1994-02-16
JPH0665290A (ja) 1994-03-08
MX9303638A (es) 1994-05-31
PL299367A1 (en) 1994-02-21
ZA934353B (en) 1994-01-13
AU4125193A (en) 1993-12-23
HU9301768D0 (en) 1993-09-28
CN1083075A (zh) 1994-03-02
SK57693A3 (en) 1994-07-06
CA2098535A1 (en) 1993-12-19
HUT66469A (en) 1994-11-28
NO932237D0 (no) 1993-06-17
NO932237L (no) 1993-12-20

Similar Documents

Publication Publication Date Title
KR940001900A (ko) 환상 유착 억제제
DE69534538D1 (de) Verzögerte Freisetzung von Peptiden aus pharmazeutischen Zusammensetzungen
TR199801115T2 (xx) Kinazolin t�revleri.
ES2029769A6 (es) Procedimiento para preparar medicamentos a base de acidos carboxilicos que contienen azufre como sustancia activa.
TR199900674T2 (xx) Kinazolin t�revleri ve bunlar� i�eren farmas�tik bile�imler.
AR018732A1 (es) Iminoazucares alquilados para prevenir, reducir o revertir la resistencia a la multidroga en el tratamiento quimioterapeutico y composicionfarmaceutica que los contiene.
RU94041223A (ru) Средство для лечения мотонейроновых заболеваний
ATE279210T1 (de) Arzneimittel freisetzendes system enthaltend ein homeobox-peptid und ein zytotoxisches oder antineoplastisches mittel
HUP9902121A2 (hu) Gonadotropin-leadó hormon antagonista hatású indolszármazékok és ezeket a vegyületeket tartalmazó gyógyszerkészítmények
KR920700200A (ko) 19-노르-비타민 d 화합물
CY1105437T1 (el) Συνθεσεις πepιεχοντας διφωσφονικα οξεα
TR200101633T2 (tr) Farmasötik bileşim
KR880006193A (ko) 피페리딘 화합물 및 그의 제조 및 용도
EP1108427A3 (en) Compositions for and uses thereof for altering gene expression with phenylacetate and derivatives thereof
DE69315699D1 (de) Inhibitoren gegen die aggregation von blutplättchen
KR940005667A (ko) 선형 펩타이드
PT1027053E (pt) Metodo de prevencao de nefrotoxicidade provocada por ciclosporinas e tacrolimus
CA2373634A1 (en) Isophosphoramide mustard analogs and use thereof
KR960034200A (ko) 항편두통성 인돌릴알킬-피리딘일 및 피리미딘일피페라진의 1,2,5-티아디아졸 유도체
KR920019350A (ko) 자기면역질환요법을 위한 약제조성물
KR870007937A (ko) 2β-치환된 티오 메틸페니실린 유도체 및 그의 제조방법 및 용도
KR890008136A (ko) 항균성 9-데옥소-9a-알릴 및 프로파길-9a-아자-9a-호모에리트로 마이신 A 유도체
KR927002224A (ko) 항종양효과증강제 및 항종양제
RU94040865A (ru) Производные пептида и их терапевтически приемлемые соли, способ их получения, фармацевтическая и косметическая композиция с антивирусной активностью
KR970704723A (ko) 항염증제로서 유용한 디히드로벤조푸란 및 관련 화합물(dihydrobenzofuran and related compounds useful as anti-inflammatory agents)

Legal Events

Date Code Title Description
PA0109 Patent application

Patent event code: PA01091R01D

Comment text: Patent Application

Patent event date: 19930617

PC1203 Withdrawal of no request for examination
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid